Study Description
The purpose of this study is to evaluate the effect of two different doses of ianalumab
added to eltrombopag to prolong Time to Treatment Failure (TTF) in adults with primary
ITP who failed previous first-line treatment with steroids. This is a multicenter, randomized, double-blinded phase 3 study to assess efficacy and
safety of two different doses of ianalumab versus placebo in addition to eltrombopag in
adults with primary ITP (platelet count <30 G/L) who failed previous first-line treatment
with corticosteroids.
After completion of the screening period, the participants will enter the randomized
treatment period (ianalumab/placebo with eltrombopag) followed by the eltrombopag
tapering period. Afterwards, all participants will enter the follow-up period to be
monitored for efficacy and safety or safety only depending on how the participants
responded to the study treatment.
Interventions
Eltrombopag
Ianalumab
Placebo
Eligibility Criteria
Key Inclusion criteria
1. Male or female patients aged 18 years and older on the day of signing the informed
consent.
2. A signed informed consent must be obtained prior to participation in the study.
3. A diagnosis of primary ITP, with insufficient response to, or relapse after a
first-line corticosteroid therapy ± IVIG.
4. Patient with platelet count <30G/L (whom eltrombopag is clinically indicated as per
physician's discretion) and with no contraindication to receive eltrombopag
Key Exclusion criteria
1. ITP patients who received second-line ITP treatments (other than steroid therapy±
IVIG) including splenectomy. However, patients exposed to thrombopoietin receptor
agonists (TPO-RAs) for a limited time (max one week) before screening are eligible.
2. Patients with key lab abnormalities and patients with Evans syndrome or any other
cytopenia, (patients with low grade anemia related to bleeding or iron deficiency
are eligible).
3. Patients with history of clinically significant hematological disorders, or with
marked altered hematologic parameters
4. Patients with current or history of life-threatening bleeding
5. Patient that are Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV),
Hepatitis B surface Antigen (HBsAg)/ Hepatitis B core antibody (HBcAb)-positive.
HBcAb-positive patients can be enrolled if HBsAg negative, HBV DNA negative, no
pre-existing liver fibrosis is present and antiviral prophylaxis is given
6. Patients with known active or uncontrolled infection requiring systemic treatment
during screening period
7. Patients with hepatic impairment
8. Patients with concurrent coagulation disorders and/or receiving antiplatelet or
anticoagulant medication with an exemption of low dose of acetylsalicylic acid (≤150
mg daily)
9. Nursing (breast feeding) or pregnant women
Other protocol-defined inclusion/exclusion criteria may apply.
Novartis Investigative Site
Recruiting
Caba,Buenos Aires,C1181ach,Argentina
Novartis Investigative Site
Recruiting
Buenos Aires,C1425aum,Argentina
Novartis Investigative Site
Recruiting
Clayton,Victoria,3168,Australia
Novartis Investigative Site
Recruiting
Parkville,Victoria,3050,Australia
Novartis Investigative Site
Recruiting
Wels,A 4600,Austria
Novartis Investigative Site
Recruiting
Linz,4010,Austria
Novartis Investigative Site
Recruiting
Vienna,A 1090,Austria
Novartis Investigative Site
Recruiting
Brugge,8000,Belgium
Novartis Investigative Site
Recruiting
Leuven,3000,Belgium
Novartis Investigative Site
Recruiting
Roeselare,8800,Belgium
Novartis Investigative Site
Recruiting
Yvoir,5530,Belgium
Novartis Investigative Site
Recruiting
Jinan,250012,China
Novartis Investigative Site
Recruiting
Guangzhou,Guangdong,510515,China
Novartis Investigative Site
Recruiting
Tianjin,300020,China
Novartis Investigative Site
Recruiting
Wuhan,Hubei,430022,China
Novartis Investigative Site
Recruiting
Tianjin,300052,China
Novartis Investigative Site
Recruiting
Suzhou,Jiangsu,215006,China
Novartis Investigative Site
Recruiting
Binzhou,Shandong,256603,China
Novartis Investigative Site
Recruiting
Hangzhou,Zhejiang,310003,China
Novartis Investigative Site
Recruiting
Beijing,100730,China
Novartis Investigative Site
Recruiting
Beijing,Beijing,100044,China
Novartis Investigative Site
Recruiting
Brno Bohunice,625 00,Czechia
Novartis Investigative Site
Recruiting
Praha 10,100 34,Czechia
Novartis Investigative Site
Recruiting
Praha,12808,Czechia
Novartis Investigative Site
Recruiting
Le Mans,72000,France
Novartis Investigative Site
Recruiting
Vandoeuvre Les Nancy,54511,France
Novartis Investigative Site
Recruiting
Blois Cedex,41000,France
Novartis Investigative Site
Recruiting
Koeln,50937,Germany
Novartis Investigative Site
Recruiting
Dresden,01307,Germany
Novartis Investigative Site
Recruiting
Giessen,35392,Germany
Novartis Investigative Site
Recruiting
Hannover,30161,Germany
Novartis Investigative Site
Recruiting
Jena,07740,Germany
Novartis Investigative Site
Recruiting
Budapest,H-1083,Hungary
Novartis Investigative Site
Recruiting
Debrecen,4032,Hungary
Novartis Investigative Site
Recruiting
Rishikesh,Uttarakhand,249203,India
Novartis Investigative Site
Recruiting
Kolkata,West Bengal,700014,India
Novartis Investigative Site
Recruiting
Chandigarh,160 012,India
Novartis Investigative Site
Recruiting
Bologna,BO,40138,Italy
Novartis Investigative Site
Recruiting
Roma,RM,00133,Italy
Novartis Investigative Site
Recruiting
Roma,RM,00168,Italy
Novartis Investigative Site
Recruiting
Torino,TO,10126,Italy
Novartis Investigative Site
Recruiting
Trieste,TS,34129,Italy
Novartis Investigative Site
Recruiting
Vicenza,VI,36100,Italy
Novartis Investigative Site
Recruiting
Suita,Osaka,565 0871,Japan
Novartis Investigative Site
Recruiting
Nagoya,Aichi,453-8511,Japan
Novartis Investigative Site
Recruiting
Bunkyo-ku,Tokyo,113-8603,Japan
Novartis Investigative Site
Recruiting
Narita,Chiba,286-8523,Japan
Novartis Investigative Site
Recruiting
Chiyoda-ku,Tokyo,101-8643,Japan
Novartis Investigative Site
Recruiting
Kumamoto-city,Kumamoto,860-0008,Japan
Novartis Investigative Site
Recruiting
Chuo ku,Tokyo,104 8560,Japan
Novartis Investigative Site
Recruiting
Omura,Nagasaki,856-8562,Japan
Novartis Investigative Site
Recruiting
Kofu-city,Yamanashi,400-8506,Japan
Novartis Investigative Site
Recruiting
Hirakata-city,Osaka,573-1191,Japan
Novartis Investigative Site
Recruiting
Aomori,030 8553,Japan
Novartis Investigative Site
Recruiting
Osaka-city,Osaka,540-0006,Japan
Novartis Investigative Site
Recruiting
Hiroshima,730-8619,Japan
Novartis Investigative Site
Recruiting
Seoul,Seocho Gu,06591,Korea, Republic of
Novartis Investigative Site
Recruiting
Seoul,06351,Korea, Republic of
Novartis Investigative Site
Recruiting
Seoul,158-710,Korea, Republic of
Novartis Investigative Site
Recruiting
Johor Bahru,80100,Malaysia
Novartis Investigative Site
Recruiting
Kuala Lumpur,56000,Malaysia
Novartis Investigative Site
Recruiting
Penang,10050,Malaysia
Novartis Investigative Site
Recruiting
Pulau Pinang,10990,Malaysia
Novartis Investigative Site
Recruiting
Kota Kinabalu,Sabah,88586,Malaysia
Novartis Investigative Site
Recruiting
Selangor,68000,Malaysia
Novartis Investigative Site
Recruiting
Kuching,Sarawak,93586,Malaysia
Novartis Investigative Site
Recruiting
Subang Jaya,Selangor,47500,Malaysia
Novartis Investigative Site
Recruiting
Monterrey,Nuevo Leon,64460,Mexico
Novartis Investigative Site
Recruiting
Saltillo,Coahuila,25230,Mexico
Novartis Investigative Site
Recruiting
Ciudad De Mexico,Mexico CP,14080,Mexico
Novartis Investigative Site
Recruiting
Morelia,Michoacan,58260,Mexico
Novartis Investigative Site
Recruiting
Leiden,Zuid Holland,2333 za,Netherlands
Novartis Investigative Site
Recruiting
Utrecht,3584cx,Netherlands
Novartis Investigative Site
Recruiting
Gralum,1714,Norway
Novartis Investigative Site
Recruiting
Makati City,1229,Philippines
Novartis Investigative Site
Recruiting
Quezon,1102,Philippines
Novartis Investigative Site
Recruiting
Bucharest,District 2,022328,Romania
Novartis Investigative Site
Recruiting
Bucharest,030 171,Romania
Novartis Investigative Site
Recruiting
Craiova,200136,Romania
Novartis Investigative Site
Recruiting
Sibiu,550245,Romania
Novartis Investigative Site
Recruiting
Timisoara,300079,Romania
Novartis Investigative Site
Recruiting
Singapore,169608,Singapore
Novartis Investigative Site
Recruiting
Singapore,S308433,Singapore
Novartis Investigative Site
Recruiting
Singapore,119074,Singapore
Novartis Investigative Site
Recruiting
Murcia,30008,Spain
Novartis Investigative Site
Recruiting
Salamanca,Castilla Y Leon,37007,Spain
Novartis Investigative Site
Recruiting
Barcelona,Catalunya,08003,Spain
Novartis Investigative Site
Recruiting
Santiago De Compostela,Galicia,15706,Spain
Novartis Investigative Site
Recruiting
Madrid,28041,Spain
Novartis Investigative Site
Recruiting
Madrid,28046,Spain
Novartis Investigative Site
Recruiting
Kaohsiung,83301,Taiwan
Novartis Investigative Site
Recruiting
Taoyuan,33305,Taiwan
Novartis Investigative Site
Recruiting
Chiang Mai,50200,Thailand
Novartis Investigative Site
Recruiting
Bangkok,10330,Thailand
Novartis Investigative Site
Recruiting
Bangkok,10700,Thailand
Novartis Investigative Site
Recruiting
Istanbul,TUR,34098,Turkey
Novartis Investigative Site
Recruiting
Ankara,06100,Turkey
Novartis Investigative Site
Recruiting
Aydin,09100,Turkey
Novartis Investigative Site
Recruiting
Edirne,22030,Turkey
Novartis Investigative Site
Recruiting
Izmir,35100,Turkey
Novartis Investigative Site
Recruiting
Samsun,55139,Turkey
Novartis Investigative Site
Recruiting
Southampton,So16 6yd,United Kingdom
Novartis Investigative Site
Recruiting
Truro,Cornwall,Tr1 3lj,United Kingdom
Novartis Investigative Site
Recruiting
London,E1 1bb,United Kingdom
Novartis Investigative Site
Recruiting
London,Sw17 0qt,United Kingdom
Novartis Investigative Site
Recruiting
London,W12 0hs,United Kingdom
Novartis Investigative Site
Recruiting
Nottingham,Ng5 1pb,United Kingdom
Novartis Investigative Site
Recruiting
Oxford,Ox3 7le,United Kingdom
St Vincent Frontier Cancer Center
Recruiting
Billings,Montana,59102,United States
Patrick Cobb
Community Cancer Trials of Utah
Recruiting
Ogden,Utah,84405,United States
Carl Gray
University of Colorado Anschutz
Recruiting
Aurora,Colorado,80045,United States
George Gemlyn
INTEGRIS Cancer Institute of Oklahoma
Recruiting
Oklahoma City,Oklahoma,73142,United States
Kellie Larsen-Dyer
Basgar Alasad
Hematology Oncology Association of Rockland
Recruiting
Nyack,New York,10960,United States
Sung Ho Lee
Yuma Regional Medical Center
Recruiting
Yuma,Arizona,85349,United States
Abhinav Chandra
Amy Olmeda
Montefiore Medical Center
Recruiting
Bronx,New York,10461,United States
Irina Murakhovskaya
UMASS Memorial Medical Center
Recruiting
Worcester,Massachusetts,01665,United States
Daniel Winokur
Uni of Chi Medi Ctr Hema and Onco
Recruiting
Chicago,Illinois,60637,United States
Michael Drazer
University of Pennsylvania
Recruiting
Philadelphia,Pennsylvania,19104,United States
Adam Cuker
Napa Research
Recruiting
Margate,Florida,33063,United States
Emilio Araujo-Mino
Community Cancer Institute
Recruiting
Clovis,California,93611,United States
Mohammed Bukari
Clinical Research Alliance
Recruiting
Lake Success,New York,11042,United States
James D Olimpio
Michigan Center of Medical Research
Recruiting
Farmington Hills,Michigan,48334,United States
Faisal Musa
Parkview Research Center
Recruiting
Fort Wayne,Indiana,46845,United States
Jeffrey Letzer
NorthShore University Health System
Recruiting
Evanston,Illinois,60201,United States
Amy Wang
Center of Clnl Rsch and Innovation
Recruiting
Houston,Texas,77008,United States
Adriana Mccray
John Knecht
Washington U Sch Of Med Ctr For CS
Recruiting
Saint Louis,Missouri,63110,United States
Morey A. Blinder
Compassionate Care Res Group Inc
Recruiting
Fountain Valley,California,92708,United States
Eric Lee
STAT Research Inc
Recruiting
Dayton,Ohio,45402,United States
Charles Bane
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.